Physician profile
William E Blalock
NPI 1740254820
$25,551.58
in general payments reported to CMS, 2019-2025
51 companies · $1,855 in 2025
The $1,855 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $935 · 2021: $716 · 2022: $1,428 · 2023: $2,486 · 2024: $2,265 · 2025: $1,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,605.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13,925.26 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,280.30 | 2019-2025 | |
| Lantheus Medical Imaging, INC. | $1,042.09 | 2019-2024 | Definity |
| Boston Scientific Corporation | $858.10 | 2019-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Pfizer INC. | $822.87 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $810.05 | 2019-2025 | Lifevest |
| Amgen INC. | $691.61 | 2019-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $686.49 | 2019-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $649.99 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $533.87 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Linq II, Cobalt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals Lp | $449.95 | 2019-2024 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $293.22 | 2021-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $280.01 | 2022-2025 | |
| Novo Nordisk INC | $268.62 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.52 | 2019-2025 | Jardiance |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $238.51 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $227.97 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $214.59 | 2019-2024 | |
| Abbott Laboratories | $195.91 | 2023-2025 | Ensite Precision, Cardiomems, Amplatzer Amulet |
| Philips North America LLC | $188.93 | 2024-2025 | (Ck4) Mcot, Ambulatory Monitoring & Diagnostics Undivided, Ecc Solutions |
| Regeneron Healthcare Solutions, INC. | $160.60 | 2019-2025 | Evkeeza, Praluent |
| Amarin Pharma, INC. | $158.62 | 2019-2022 | |
| Portola Pharmaceuticals, LLC | $128.75 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $100.20 | 2024 | Arcalyst |
| Lundbeck LLC | $93.60 | 2019 | |
| Arbor Pharmaceuticals, INC. | $90.16 | 2019-2021 | |
| Daiichi Sankyo INC. | $85.57 | 2019-2024 | Injectafer |
| Janssen Scientific Affairs, LLC | $82.27 | 2022-2023 | Xarelto |
| Atricure, INC. | $69.84 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $65.58 | 2024-2025 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $62.73 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $54.74 | 2023-2024 | Edarbi, Edarbyclor |
| Scpharmaceuticals INC. | $51.36 | 2023-2024 | |
| Gilead Sciences, INC. | $47.60 | 2019 | |
| Bridgebio Pharma, INC. | $45.61 | 2025 | Attruby |
| Akcea Therapeutics, INC. | $38.45 | 2020 | |
| Cvrx, INC. | $30.95 | 2024 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $26.25 | 2025 | Assure Wcd |
| Grifols USA, LLC | $24.36 | 2021 | |
| Catheter Precision INC. | $24.14 | 2024 | |
| Medtronic Vascular, INC. | $22.61 | 2019-2020 | |
| Stryker Corporation | $22.48 | 2025 | Flowtriever |
| Ge Healthcare | $19.60 | 2023 | |
| Chiesi USA, INC. | $19.34 | 2025 | Juxtapid |
| Kiniksa Pharmaceuticals, Ltd. | $19.03 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $17.89 | 2024 | Zio Xt Patch, Zio Monitor |
| Biosense Webster, INC. | $17.71 | 2024 | Nuvision Ice Catheter |
| Aegerion Pharmaceuticals, INC. | $15.94 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.93 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.81 | 2020 | |
| Bardy Diagnostics, INC. | $8.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Blalock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.